Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

COVID-19 can cause hair loss, but specialists can help treat it.

COVID-19 can cause skin problems in children.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Some drugs may help treat both COVID-19 and radiation injury.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

COVID-19 can cause various skin issues, including rashes and lesions.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Early identification of lupus through skin signs and blood tests is crucial in India.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.